Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Heparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins
Lianchun Wang, … , Ajit Varki, Jeffrey D. Esko
Lianchun Wang, … , Ajit Varki, Jeffrey D. Esko
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):127-136. https://doi.org/10.1172/JCI14996.
View: Text | PDF
Article Vascular biology

Heparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins

  • Text
  • PDF
Abstract

Research Article

Authors

Lianchun Wang, Jillian R. Brown, Ajit Varki, Jeffrey D. Esko

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of oxazolone-induced ear swelling in sensitized mice. Mice we...
Inhibition of oxazolone-induced ear swelling in sensitized mice. Mice were sensitized to oxazolone and rechallenged by topical treatment of one ear (see Methods). Swelling was measured by ear thickness, and the value obtained from the vehicle-treated control ear was subtracted from those obtained from oxazolone-treated mice. (a) Animals received a single intravenous injection of heparin (1 mg), heparin derivative (1 mg), or saline within 30 minutes after antigen challenge. *Significant difference in ear swelling in the control mice injected with saline (gray bar) versus those that were injected with the heparin derivatives (black bars). (b) Sensitized wild-type and selectin-deficient mice were injected with heparin (1 mg) and rechallenged with antigen as in a. Each bar represents the average value ± SD; n = 5–8. *Significant difference in ear swelling in mice treated with heparin (black bars) versus control mice that received only saline (gray bars).
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts